Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study
Authors
Keywords
-
Journal
JOURNAL OF GASTROINTESTINAL SURGERY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-03
DOI
10.1007/s11605-022-05421-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of the efficacy and safety of conventional transarterial chemoembolization with and without drug‐eluting beads embolization for the treatment of unresectable large hepatocellular carcinoma
- (2021) Shiguang Chen et al. HEPATOLOGY RESEARCH
- Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
- (2021) Masatoshi Kudo et al. Liver Cancer
- Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma
- (2021) Run-Bin Liang et al. Frontiers in Oncology
- Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with intermediate and advanced stage hepatocellular carcinoma: A phase II, single-arm, prospective study
- (2020) Shiguang Chen et al. EUROPEAN JOURNAL OF CANCER
- Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma
- (2020) Wei-Lun Tsai et al. MEDICINE
- Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
- (2019) MinKe He et al. JAMA Oncology
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016
- (2016) Stephen L Chan et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The use of and adherence to CTCAE v3.0 in cancer clinical trial publications
- (2016) Sheng Zhang et al. Oncotarget
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Current Status of Hepatic Arterial Infusion Chemotherapy
- (2015) Shuntaro Obi et al. Liver Cancer
- Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan
- (2013) K Nouso et al. BRITISH JOURNAL OF CANCER
- Hepatocellular Carcinoma: Illustrated Guide to Systematic Radiologic Diagnosis and Staging According to Guidelines of the American Association for the Study of Liver Diseases
- (2013) Sinead H. McEvoy et al. RADIOGRAPHICS
- Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
- (2010) Peter C. Austin PHARMACEUTICAL STATISTICS
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started